Net Cash Provided by (Used in) Operating Activities |
-736 K |
USD |
-20.7% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-85 K |
USD |
-100% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
475 K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-347 K |
USD |
-129% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
444 K |
USD |
-62.9% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
216 K |
USD |
+10824% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Gross |
216 K |
USD |
+10824% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
214 K |
USD |
+10724% |
Dec 31, 2023 |
2023 |
Preferred Stock, Shares Authorized |
1 M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
1.2 M |
USD |
|
Dec 31, 2023 |
2023 |
Deferred Tax Assets, Net of Valuation Allowance |
273 K |
USD |
+317% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |